Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Oxford Nanopore Technologies
Oxford Nanopore Technologies
Activities:
Manufacturing
Research & Development
X
LinkedIn
Trending Articles
IMPACT CKD model reveals the escalating toll of chronic kidney disease
The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Isospec Analytics launches biomolecular analysis technology to identify unknown molecules
The novel technology optimises the identification process of unknown molecules compared to mass analysis
Building strong foundations for a resilient and planet-friendly future
Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector
The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Manufacturing
Oxford Nanopore automates flow cell production at new UK facility
Besides flow cells, the MinION building integrates processes that are typically found in other industries; semiconductor manufacture, life sciences and computational tool development
Research & Development
Oxford Nanopore gets cash injection
Biotech company Amgen has announced a £50m (US$66m) equity investment in the UK-based company developing real-time genetic sequencing technology
Training & Education
BIA launches Genomics Advisory Committee at annual summit
Research & Development
Oxford Nanopore raises £35m through private share placement
The funds will be used to scale up production and logistics for its MinION devices
Research & Development
Oxford Nanopore Technologies to expand hq
Venture capital funds will support expansion in Oxford and opening of Cambridge informatics outpost
Subscribe now